Revenue: The sum of all revenue fields included for a company's operating activities.
Interpace Biosciences, Inc. (IDXG) had Revenue of $46.93M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$46.93M |
$6.24M |
|
$17.00M |
|
$29.93M |
|
$38.82M |
|
$8.11M |
|
$-1.16M |
|
$6.95M |
|
$6.95M |
|
$6.95M |
|
$6.95M |
|
$6.70M |
|
$6.95M |
|
$8.11M |
|
$8.86M |
|
4.39M |
|
15.73M |
|
$1.42 |
|
$0.40 |
|
| Balance Sheet Financials | |
$11.77M |
|
$1.36M |
|
$3.02M |
|
$14.79M |
|
$10.62M |
|
-- |
|
$6.39M |
|
$17.01M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
4.41M |
|
| Cash Flow Statement Financials | |
$4.65M |
|
$-0.88M |
|
$-5.81M |
|
$3.50M |
|
$1.46M |
|
$-2.04M |
|
$0.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.11 |
|
-- |
|
-- |
|
-- |
|
-1.94 |
|
63.77% |
|
17.28% |
|
17.28% |
|
18.87% |
|
14.81% |
|
13.29% |
|
$3.77M |
|
-- |
|
-- |
|
-- |
|
3.17 |
|
-- |
|
5.49 |
|
66.46 |
|
-313.31% |
|
-313.31% |
|
46.96% |
|
-313.31% |
|
$-0.50 |
|
$0.24 |
|
$0.30 |
|